Approval Year
| Substance Class |
Mixture
Created
by
admin
on
Edited
Mon Mar 31 18:11:57 GMT 2025
by
admin
on
Mon Mar 31 18:11:57 GMT 2025
|
| Record UNII |
IU5QR144QX
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WHO-ATC |
G03CC07
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
WHO-ATC |
G03CA57
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
EMA ASSESSMENT REPORTS |
DUAVIVE (AUTHORIZED: OSTEOPOROSIS)
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
NDF-RT |
N0000167510
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
WHO-VATC |
QG03CA57
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
NDF-RT |
N0000175825
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
||
|
NDF-RT |
N0000000100
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
SUB13722MIG
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
DB00286
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
IU5QR144QX
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
DTXSID9021186
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
8389
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
IU5QR144QX
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
100000088320
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
235-199-5
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
C482
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
4855
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
4099
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
PREMARIN
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
3076
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
m3762
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | Merck Index | ||
|
CHEMBL1201649
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY | |||
|
12126-59-9
Created by
admin on Mon Mar 31 18:11:57 GMT 2025 , Edited by admin on Mon Mar 31 18:11:57 GMT 2025
|
PRIMARY |
All of the following components must be present:
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
